N
Nutriband Inc. (NTRB)
NCM – Real vaqt narxi. Valyuta: USD
3.06
+0.03 (0.99%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.06
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.06
+0.03 (0.99%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.06
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Nutriband Inc. Qo'shma Shtatlarda transdermal farmatsevtika mahsulotlari portfelini ishlab chiqadi. Uning yetakchi mahsuloti surunkali og'riqni davolash uchun buzishdan himoyalangan fentanil yamasi bo'lgan AVERSA Fentanyl hisoblanadi. Kompaniya, shuningdek, AVERSA buprenorphine va AVERSA methylphenidate ni ishlab chiqadi. U Kindeva Drug Delivery bilan Aversa Fentanyl uchun tijoriy rivojlanish va klinik ta'minot shartnomasiga ega. Kompaniya 2016 yilda ro'yxatga olingan va shtab-kvartirasi Orlando, Florida shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Alan Smith Ph.D. | COO & President of 4P Therapeutics |
| Dr. Jeffrey Patrick Pharm.D. | Chief Scientific Officer |
| Mr. Gareth Sheridan | Founder, CEO & Director |
| Mr. Gerald Goodman | CFO & Chief Accounting Officer |
| Mr. Michael Myer | President of Pocono Pharmaceutical |
| Mr. Serguei Melnik | Founder, President, Company Secretary & Executive Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-22 | 8-K | ea0295410-8k_nutriband.htm |
| 2026-06-11 | 10-Q | ea0294013-10q_nutriband.htm |
| 2026-05-18 | 10-K/A | ea0290874-10ka1_nutriband.htm |
| 2026-04-29 | 10-K | ea0287168-10k_nutriband.htm |
| 2026-04-07 | 8-K | ea0285330-8k_nutriband.htm |
| 2026-02-13 | 8-K | ea0277156-8k_nutriband.htm |
| 2026-02-03 | 8-K | ea0275277-8k_nutriband.htm |
| 2025-12-30 | 8-K | ea0271298-8k_nutriband.htm |
| 2025-12-19 | DEF 14A | ea0267930-01.htm |
| 2025-12-11 | 10-Q | ea0268722-10q_nutriband.htm |
| Mr. Tyler Overk | Head of Active Intelligence |